A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug

被引:44
作者
Pillay, V [1 ]
Fassihi, R [1 ]
机构
[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA
关键词
lipid-filled capsules; dissolution method; lipidsoluble drugs; softgel capsules;
D O I
10.1023/A:1011959914706
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
[No abstract available]
引用
收藏
页码:333 / 337
页数:5
相关论文
共 10 条
[1]
Dissolution media for in vitro testing of water-insoluble drugs: Effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate [J].
Crison, JR ;
Weiner, ND ;
Amidon, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :384-388
[2]
*CTR DRUG EV RES C, 1997, GUID IND DISS TEST I
[3]
ESTABLISHMENT OF SINK CONDITIONS IN DISSOLUTION RATE DETERMINATIONS - THEORETICAL CONSIDERATIONS AND APPLICATION TO NONDISINTEGRATING DOSAGE FORMS [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (10) :1238-&
[4]
Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system .1. Description of a two-phase in vitro dissolution test [J].
Grundy, JS ;
Anderson, KE ;
Rogers, JA ;
Foster, RT .
JOURNAL OF CONTROLLED RELEASE, 1997, 48 (01) :1-8
[5]
Moore J.W., 1996, PHARM TECHNOL, V20, P64, DOI DOI 10.1017/CCOL521633230.011
[6]
Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method [J].
Pillay, V ;
Fassihi, R .
JOURNAL OF CONTROLLED RELEASE, 1998, 55 (01) :45-55
[7]
EFFECT OF VEHICLE AMPHIPHILICITY ON THE DISSOLUTION AND BIOAVAILABILITY OF A POORLY WATER-SOLUBLE DRUG FROM SOLID DISPERSIONS [J].
SERAJUDDIN, ATM ;
SHEEN, PC ;
MUFSON, D ;
BERNSTEIN, DF ;
AUGUSTINE, MA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (05) :414-417
[8]
Shah N. H., 1993, B TECH GATTEFORSSE, V85, P45
[9]
BIOAVAILABILITY OF A POORLY WATER-SOLUBLE DRUG FROM TABLET AND SOLID DISPERSION IN HUMANS [J].
SHEEN, PC ;
KIM, SI ;
PETILLO, JJ ;
SERAJUDDIN, ATM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (07) :712-714
[10]
*US PHARM CONV INC, 1995, 23NF18 USP US PHARM